AN OPEN-LABEL TRIAL OF MILACEMIDE IN SCHIZOPHRENIA - AN NMDA INTERVENTION STRATEGY

被引：34

作者：

ROSSE, RB

SCHWARTZ, BL

LEIGHTON, MP

DAVIS, RE

DEUTSCH, SI

机构：

[1] DEPT VET AFFAIRS MED CTR,PSYCHIAT SERV 688-116A,SO IRVING ST NW,WASHINGTON,DC 20422

[2] GEORGETOWN UNIV,SCH MED,WASHINGTON,DC 20007

来源：

CLINICAL NEUROPHARMACOLOGY | 1990年 / 13卷 / 04期

关键词：

D O I：

10.1097/00002826-199008000-00010

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：348 / 354

页数：7

共 24 条

[1]

ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789

[2]

ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P784

[3]

BONATO GW, 1970, MANUAL ECDU ASSESSME

[4]

CHRISTOPHE J, 1986, LIFE SCI, V33, P533

[5] A GLUTAMATERGIC HYPOTHESIS OF SCHIZOPHRENIA - RATIONALE FOR PHARMACOTHERAPY WITH GLYCINE [J].

DEUTSCH, SI ;

MASTROPAOLO, J ;

SCHWARTZ, BL ;

ROSSE, RB ;

MORIHISA, JM .

CLINICAL NEUROPHARMACOLOGY, 1989, 12 (01) :1-13

[6]

DEVAREBEKE PJ, 1988, J NEUROCHEM, V50, P1011

[7] PHENCYCLIDINE AND RELATED DRUGS BIND TO THE ACTIVATED N-METHYL-D-ASPARTATE RECEPTOR CHANNEL COMPLEX IN RAT-BRAIN MEMBRANES [J].

FAGG, GE .

NEUROSCIENCE LETTERS, 1987, 76 (02) :221-227

[8] THE NOVEL ANTICONVULSANT MK-801 BINDS TO THE ACTIVATED STATE OF THE N-METHYL-D-ASPARTATE RECEPTOR IN RAT-BRAIN [J].

FOSTER, AC ;

WONG, EHF .

BRITISH JOURNAL OF PHARMACOLOGY, 1987, 91 (02) :403-409

[9]

HANDELMANN GE, 1989, BIOCH PHARM BEHAV, V34, P823

[10]

Heaton R.K., 1981, PSYCHOL ASSESS RESOU

← 1 2 3 →